Quantitation of glycosaminoglycan metabolism in anatomically intact articular cartilage of the mouse patella: in vitro and in vivo studies with 35S-sulfate, 3H-glucosamine, and 3H-acetate
- PMID: 3809888
- DOI: 10.1007/BF00541319
Quantitation of glycosaminoglycan metabolism in anatomically intact articular cartilage of the mouse patella: in vitro and in vivo studies with 35S-sulfate, 3H-glucosamine, and 3H-acetate
Abstract
We investigated the usefulness of the whole mouse patella to quantitate the synthesis of the glycosaminoglycan (GAG) backbone and its sulfation by intact murine articular cartilage, both in vitro and in vivo. Using 35S-sulfate, 3H-glucosamine, or 3H-acetate as precursors of GAG synthesis, it was found that more than 90% of the incorporated radioactivity was confined to the patellar cartilage layer compared to the whole patella. Overnight papain digestion was enough to liberate more than 95% of the incorporated radiolabels, except for 3H-acetate for which 15-25% was not digestible. Comparison of radioactivity in the patella and that in quantitatively isolated GAGs revealed that for 35S-sulfate incorporation studies the whole patella can be used as a reliable measure for sulfated GAG synthesis. The situation was different for the GAG backbone precursors 3H-glucosamine and 3H-acetate; more than 50% of the 3H labels were incorporated into compounds other than GAGs or non-covalently associated with matrix components. Hence, in studying GAG-backbone metabolism, polysaccharides must be isolated quantitatively from cartilage. In vivo studies made it clear that both 35S-sulfate and 3H-glucosamine are incorporated into patellar GAGs in amounts high enough to enable proper quantitation and that the route of administration (intraperitoneally or intravenously) is of minor importance. Due to its low specificity for cartilage GAGs, 3H-acetate is not suitable for such studies.
Similar articles
-
Salicylate-induced depletion of endogenous inorganic sulfate. Potential role in the suppression of sulfated glycosaminoglycan synthesis in murine articular cartilage.Arthritis Rheum. 1985 Aug;28(8):922-9. doi: 10.1002/art.1780280812. Arthritis Rheum. 1985. PMID: 4026888
-
Molybdate impairs glycosaminoglycan sulfation in rat cartilage.Toxicol Appl Pharmacol. 1996 Feb;136(2):354-60. doi: 10.1006/taap.1996.0043. Toxicol Appl Pharmacol. 1996. PMID: 8619244
-
The effect of salicylate on anatomically intact articular cartilage is influenced by sulfate and serum in the culture medium.J Rheumatol. 1986 Aug;13(4):686-93. J Rheumatol. 1986. PMID: 3772916
-
Effects of treadmill running on glycosaminoglycans in articular cartilage of rabbits.Int J Sports Med. 1984 Dec;5(6):320-4. doi: 10.1055/s-2008-1025925. Int J Sports Med. 1984. PMID: 6511150
-
The effect of aging on the synthesis of hexosamine-containing substances from rat costal cartilage. A decrease in sulfation of chondroitin sulfate with aging.J Biochem. 1979 Feb;85(2):519-28. doi: 10.1093/oxfordjournals.jbchem.a132359. J Biochem. 1979. PMID: 422544
Cited by
-
Immobilization aggravates cartilage damage during antigen-induced arthritis in mice. Attachment of polymorphonuclear leukocytes to articular cartilage.Am J Pathol. 1990 Jun;136(6):1407-16. Am J Pathol. 1990. PMID: 2356866 Free PMC article.
-
Xylosyltransferase-I regulates glycosaminoglycan synthesis during the pathogenic process of human osteoarthritis.PLoS One. 2012;7(3):e34020. doi: 10.1371/journal.pone.0034020. Epub 2012 Mar 30. PLoS One. 2012. PMID: 22479506 Free PMC article.
-
Effects of NSAIDs on the metabolism of sulphated glycosaminoglycans in healthy and (post) arthritic murine articular cartilage.Drugs. 1988;35 Suppl 1:24-32. doi: 10.2165/00003495-198800351-00007. Drugs. 1988. PMID: 3359944
-
Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling.Arthritis Res Ther. 2007;9(5):R102. doi: 10.1186/ar2305. Arthritis Res Ther. 2007. PMID: 17922907 Free PMC article.
-
Targeting of Proteoglycan Synthesis Pathway: A New Strategy to Counteract Excessive Matrix Proteoglycan Deposition and Transforming Growth Factor-β1-Induced Fibrotic Phenotype in Lung Fibroblasts.PLoS One. 2016 Jan 11;11(1):e0146499. doi: 10.1371/journal.pone.0146499. eCollection 2016. PLoS One. 2016. PMID: 26751072 Free PMC article.